262 results
Page 4 of 14
S-8
EX-5.1
dpax8su8boqu
30 Apr 21
Registration of securities for employees
12:00am
424B5
bw4eesycc
26 Jan 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-5.1
hjrgdc2
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm
8-K
EX-1.1
texov47qvvhzhv
26 Jan 21
Seelos Therapeutics Announces Pricing of $31.25 Million Public Offering of Common Stock
5:09pm
424B5
jwvmdzbxtrwizekku
25 Jan 21
Prospectus supplement for primary offering
4:16pm
8-K
EX-10.1
5ql7l5xp mjlnzk7f7d
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-4.1
6kbtb8jef8e5k1fdllek
17 Dec 20
Entry into a Material Definitive Agreement
4:05pm
424B3
4ole6izos 3d
4 Dec 20
Prospectus supplement
4:48pm
8-K
EX-10.1
kzknmv7n790v7vxanj6
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
8-K
EX-5.1
s8eiszoa9d2wrxdfl
9 Sep 20
Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
4:02pm
424B5
vsczg6g0k0sqtq 2cfj
8 Sep 20
Prospectus supplement for primary offering
4:43pm